Express Scripts (ESRX) Reports In-Line Q1 EPS

Go back to Express Scripts (ESRX) Reports In-Line Q1 EPS

Express Scripts (ESRX) PT Lifted to $95 at Leerink Partners; Likely to Remain Standalone PBM

April 29, 2015 1:21 PM EDT

Leerink Partners analyst David Larsen reiterated an Outperform rating and lifted his price target on Express Scripts (NASDAQ: ESRX) to $95.00 (from $90.00) following Q1 results. The analyst said the company is likely to remain a standalone PBM.

Larsen commented, "Following ESRX' 1Q:15... More